Results 141 to 150 of about 99,459 (305)

Photoaging and Cosmetic Result with Artificial Daylight Photo­dynamic Therapy Using Methyl Aminolevulinate

open access: yesActa Dermato-Venereologica
Artificial daylight photodynamic therapy with methyl aminolevulinate is an effective and almost painless treatment approach for actinic keratoses. The objective of the prospective, non-interventional, multicentre study ArtLight (NCT05725213) was to gain ...
Rolf-Markus Szeimies   +10 more
doaj   +1 more source

System level network data and models attack cancer drug resistance

open access: yesBritish Journal of Pharmacology, EarlyView.
Drug resistance is responsible for >90% of cancer related deaths. Cancer drug resistance is a system level network phenomenon covering the entire cell. Small‐scale interactomes and signalling network models of drug resistance guide directed drug development.
Márk Kerestély   +6 more
wiley   +1 more source

Frontline Venetoclax Therapy for 18-Year-Old Male with Ataxia Telangiectasia and Early T-Cell Precursor Acute Lymphoblastic Leukemia [PDF]

open access: bronze, 2023
Shaikha Alqahtani   +6 more
openalex   +1 more source

Tratamiento quirúrgico de rinofima. Presentación de dos casos

open access: yesMedisur, 2016
El rinofima es una enfermedad de la piel de la nariz, consistente en una hipertrofia de las glándulas sebáceas locales que conlleva a una deformación característica. Se presenta con hipertrofia de la piel, inflamación crónica, aumento del tejido vascular,
Bernaldo Canto Vidal   +2 more
doaj   +2 more sources

Supplementary Data from First-in-Human Trial of the Oral Ataxia Telangiectasia and RAD3-Related (ATR) Inhibitor BAY 1895344 in Patients with Advanced Solid Tumors [PDF]

open access: gold, 2023
Timothy A. Yap   +23 more
openalex   +1 more source

Non‐Coding RNAs in Breast Cancer Radioresistance: Mechanisms, Functional Roles and Translational Potentials

open access: yesCell Proliferation, EarlyView.
Non‐coding RNAs (ncRNAs) regulate breast cancer radioresistance via cell cycle, DNA repair and tumour microenvironment pathways. Targeting ncRNAs (e.g., HOTAIR and miR‐155) with RNA‐based therapies (ASOs and CRISPR) shows promise but faces delivery challenges.
Xiaohui Zhao   +8 more
wiley   +1 more source

ATAXIA-TELANGIECTASIA

open access: yesMedicine, 1972
D E, McFarlin, W, Strober, T A, Waldmann
openaire   +2 more sources

Home - About - Disclaimer - Privacy